Quantcast

See headlines for LVVV
View Print Version
More from GlobeNewswire

LiveWire Ergogenics Announces Distribution and Private Label Agreement with Basso Botanicals - First Manufacturer to Implement LiveWire’s 7X Pure™ Dosing and Verification System

By GlobeNewswire,  April 16, 2019, 09:30:00 AM EDT

LiveWire Ergogenics Announces Distribution and Private Label Agreement with Basso Botanicals - First Manufacturer to Implement LiveWire's 7X Pure™ Dosing and Verification System


Anaheim, CA, April 16, 2019 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC:LVVV) announced today the Company has entered into a Distribution and Private Label Agreement with Basso Botanicals, a manufacturer of organically grown, full-plant, full-spectrum, active hemp oil extracts in a variety of products to help people and animals experience its various health benefits and promote a healthy lifestyle. Basso Botanicals will also be the first manufacturer to implement LiveWire's 7X Pure™ Dosing and Verification system to ensure consumers Basso products are of the highest quality.

Basso Botanicals




Basso Botanicals was founded in 2017 by Dale Hall and a group of individuals with a passion for the cannabis industry. This passion evolved further with the gathering of in-depth knowledge about the benefits of CBD and how it has been helping specific ailments or conditions for human and veterinarian applications that conventional medicine could not always adequately address. The Company's mission is to be an industry leader in providing the highest quality CBD and cannabis products to aid in a variety of medical conditions and support healthy living.

Bill Hodson, CEO of LiveWire Ergogenics, Inc states, "Dale's passion for quality and transparency, translate into some of the best products I've seen in the industry. We share a vision for the future, not only in product development and distribution channels, but also the importance of an extremely high set of standards, and the 7X Pure ™ Dosage and Verification system fits perfectly . Basso Botanicals is well-respected in the industry and its quest to develop only the highest quality pharmaceutical grade products for the consumer perfectly mirrors LiveWire's approach to a changing cannabis industry whose customers' demand clean, high-quality and certified product. This relationship supports our continued efforts to become the leading, vertically integrated cannabis company."

Basso Botanicals' forward-thinking management team is working diligently to provide organically grown, full-plant, full-spectrum CBD in a variety of products. These products currently include tinctures/oils, topicals, gel caps, gummies, and dog treats that are of the highest quality elements and tested free of THC. Basso Botanicals provides the highest quality full-spectrum, whole plant extractions from Hemp plants grown in America. This process ensures that all essential vitamins, minerals, fatty acids, proteins, and anti-oxidants are available in all products.

Basso Botanicals' pharmaceutical grade products are THC-free, non-GMO, and free from any harmful preservatives or added ingredients with third-party lab certification identifying the contents of all our products. For more information visit https://bassobotanicals.com

Basso Botanicals is the first manufacturer that will implement LiveWire's 7X Pure™ Dosing and Verification system to verify and certify the dosing and pureness of all products manufactured by Basso and distributed by LiveWire. LiveWire's plan is to establish its 7X Pure™ Verification System as the gold standard in the industry. For more information please visit 7xPure.com

In cooperation with Basso Botanicals' team LiveWire will also begin the development and production of Private Label LiveWire 7X Pure™ tested high-end CBD and cannabis products and market and distribute these products worldwide.

For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For non-material updates, follow LiveWire Ergogenics on Twitter @livewireLVVV. Download the Stockwatchindex Research Report at www.swiresearch.com/report-index

About LiveWire Ergogenics, Inc.

LiveWire Ergogenics, Inc. specializes in identifying and monetizing current and future trends in the health and wellness industry, with a focus on the cannabis sector. The Company acquires, manages and licenses specialized real estate locations for fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California. Through its subsidiary GHC Ventures It has been awarded several permits for the Company's nursery locations in California and a Statewide distribution license. The Company is also entering into research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large "sufferer" populations for human and veterinarian applications. This includes dosing verification of zero pesticide products for quality brands via the Company's 7X Pure™ Cannabis Dosing and Verification System, and development and licensing of legal, high-quality cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the Unites States Controlled Substance Act.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company's products, or any of the Company's other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results and performance, events or circumstances, and actual events may differ materially. Factors that may cause actual results to differ materially from any projections may include, without limitation, delays in the development of its products, the impact of significant new or changing government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company's inability to obtain additional financing for the implementation of the Company's business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.

INVESTOR CONTACT

Brian Barnes

EquiNet, LLC

Toll free: 877-964-6463

Direct: 858-264-6500

LIVEWIRE ERGOGENICS INC.

1600 North Kraemer Blvd.

Anaheim, CA 92806

714-740-5144

www.livewireergogenics.com

info@livewireergogenics.com

MARKET AWARENESS

Stockwatchindex, LLC

www.stockwatchindex.com

info@stockwatchindex.com

Attachment

Source: LiveWire Ergogenics, Inc

This article appears in: News Headlines

Referenced Stocks: LVVV










Today's Market Activity

NASDAQ 7998.06
1.98  ▲  0.02%
DJIA 26559.54
110.00  ▲  0.42%
S&P 500 2905.03
4.58  ▲  0.16%
Data as of Apr 18, 2019